Lin YH, Zhang ZJ, Zhong JQ, Wang ZY, et al. Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial. PLoS One 2024;19:e0302155.
PMID: 38701096